These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33362690)

  • 1. Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration.
    Quiroz-Baez R; Hernández-Ortega K; Martínez-Martínez E
    Front Neurol; 2020; 11():580030. PubMed ID: 33362690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease.
    Wang S; Kojima K; Mobley JA; West AB
    EBioMedicine; 2019 Jul; 45():351-361. PubMed ID: 31229437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.
    Hurwitz SN; Sun L; Cole KY; Ford CR; Olcese JM; Meckes DG
    J Neurosci Methods; 2018 Sep; 307():210-220. PubMed ID: 29894726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.
    Izco M; Carlos E; Alvarez-Erviti L
    Neurobiol Dis; 2022 May; 166():105651. PubMed ID: 35124191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids.
    Vaz M; Soares Martins T; Henriques AG
    J Neurochem; 2022 Nov; 163(4):266-309. PubMed ID: 36156258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics profiling of extracellular vesicle for identification of potential biomarkers in Alzheimer's disease: A comprehensive review.
    Pei J; Palanisamy CP; Jayaraman S; Natarajan PM; Umapathy VR; Roy JR; Thalamati D; Ahalliya RM; Kanniappan GV; Mironescu M
    Ageing Res Rev; 2024 Aug; 99():102359. PubMed ID: 38821418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 9. Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges.
    Lee S; Mankhong S; Kang JH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications.
    Khan NA; Asim M; El-Menyar A; Biswas KH; Rizoli S; Al-Thani H
    Front Aging Neurosci; 2022; 14():933434. PubMed ID: 36275010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword.
    Trotta T; Panaro MA; Cianciulli A; Mori G; Di Benedetto A; Porro C
    Biochem Pharmacol; 2018 Feb; 148():184-192. PubMed ID: 29305855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
    Gao S; Casey AE; Sargeant TJ; Mäkinen VP
    Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome Biomarkers Revolutionize Preclinical Diagnosis of Neurodegenerative Diseases and Assessment of Treatment Responses in Clinical Trials.
    Kapogiannis D
    Adv Exp Med Biol; 2020; 1195():149. PubMed ID: 32468469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications.
    Izadpanah M; Seddigh A; Ebrahimi Barough S; Fazeli SAS; Ai J
    J Mol Neurosci; 2018 Oct; 66(2):172-179. PubMed ID: 30140997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease.
    Couch Y
    Expert Rev Mol Diagn; 2023; 23(12):1091-1105. PubMed ID: 37916853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
    Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics.
    Kreimer S; Belov AM; Ghiran I; Murthy SK; Frank DA; Ivanov AR
    J Proteome Res; 2015 Jun; 14(6):2367-84. PubMed ID: 25927954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin.
    Younas N; Fernandez Flores LC; Hopfner F; Höglinger GU; Zerr I
    Transl Neurodegener; 2022 May; 11(1):28. PubMed ID: 35527262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.